1. Home
  2. HIG vs TEVA Comparison

HIG vs TEVA Comparison

Compare HIG & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hartford Financial Services Group Inc. (The)

HIG

Hartford Financial Services Group Inc. (The)

HOLD

Current Price

$138.73

Market Cap

37.3B

Sector

Finance

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$31.71

Market Cap

33.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIG
TEVA
Founded
1810
1901
Country
United States
Israel
Employees
19200
32842
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.3B
33.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HIG
TEVA
Price
$138.73
$31.71
Analyst Decision
Buy
Strong Buy
Analyst Count
17
8
Target Price
$149.38
$38.63
AVG Volume (30 Days)
1.1M
5.2M
Earning Date
04-23-2026
04-29-2026
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.06
N/A
Revenue Next Year
$4.13
$3.24
P/E Ratio
$10.61
$28.19
Revenue Growth
N/A
N/A
52 Week Low
$113.27
$13.04
52 Week High
$143.98
$37.35

Technical Indicators

Market Signals
Indicator
HIG
TEVA
Relative Strength Index (RSI) 55.32 58.60
Support Level $129.04 $30.70
Resistance Level $139.25 $31.99
Average True Range (ATR) 2.46 0.94
MACD 0.61 0.37
Stochastic Oscillator 70.91 93.91

Price Performance

Historical Comparison
HIG
TEVA

About HIG Hartford Financial Services Group Inc. (The)

The Hartford Insurance Group Inc. provides property and casualty insurance, group benefits, and mutual funds. The company is widely recognized for its service excellence, sustainability practices, trust, and integrity. The Company currently conducts business principally in five reportable segments, including Business Insurance, Personal Insurance, Property & Casualty Other Operations, Employee Benefits, and Hartford Funds, as well as a Corporate category. The company generates a majority of its revenue from Business Insurance.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: